NaDeNo | Drug delivery platform for hard-to-deliver drugs

NaDeNo’s drug delivery platform is designed to unlock the therapeutic potential of hard-to-deliver drugs. Many promising drug candidates fail to translate into clinical benefit because they cannot reach the target tissue effectively, often due to poor solubility, limited tissue penetration, or rapid clearance. NaDeNo addresses these challenges by encapsulating active drug molecules in proprietary nanoparticles that enable local delivery, improved retention, controlled release, and adaptable targeting, without chemically modifying the drug itself.

This preserves the drug’s intended mode of action upon release while creating opportunities to improve exposure at the target tissue and reduce off-target limitations. The platform has demonstrated versatility across multiple drug classes, administration routes, and targeting approaches, and is supported by a patented, sustainable, and scalable one-step manufacturing process. NaDeNo is seeking co-development and licensing partnerships with companies looking to differentiate existing or novel assets through advanced delivery technology.